Insights

Sepsis is a life-threatening response of the immune system to infection that can lead to tissue damage, organ failure and the risk of permanent disability or death. Detecting and treating it early can be highly effective in stopping progression. The trouble is that implementing the level of monitoring required to catch sepsis at the earliest stages is tough outside critical care settings. 

The medical implant industry is set to grow from $5bn in 2017 to $16.3bn by 2022. But there are tensions to understand and hurdles to overcome for innovators intent on taking advantage.

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

Technology is advancing at a remarkable pace. Can regulatory agencies keep up? They are working hard at that and in that process come many changes. The line between what is a consumer device and what is a...

The number of effective cell and gene therapies is growing rapidly, especially for treating ocular diseases. However, much less attention has been focused on the critical issue of delivery to the eye. 

If you’re a surgical robotics start-up, the timing of your risk assessment will determine the level of success you achieve. Andrew Savarese, VP, Surgical Robotics & Advanced Surgical Systems, delves into his deep experience and comes up with crucial advice to make sure you spend the right money once, not the wrong money twice.

The pandemic has compressed a decade of incremental change into a matter of months. Medical device companies sit on the cusp of radical change. Gavin Troughton, Head of Acute and Critical Care, surveys the fast changing landscape and poses the questions that can inform your digital transformation play…

Diagnosing cancer early to treat it more effectively is vital. Here, Josh Gibson, senior physicist at Cambridge Consultants, unveils a potentially life-saving breakthrough in the field of liquid biopsy that’s been hailed by a leading innovation award jury…

Intraocular lens (IOL) delivery devices are the next frontier for innovation and differentiation. As the optical quality of the IOL is reaching its apex, there's little room for competitive differentiation in the lens itself. Tim Phillips explores the improvements to IOL delivery devices that could reduce complications, streamline delivery workflow and improve postoperative patient satisfaction.

With the increasing need for remote diagnosis and monitoring, telehealth solutions are on the rise. But how do you choose the correct data strategy to deal with the wealth of data – is there a trade off?

The past year has seen an unprecedented acceleration of innovation in the diagnostics space. Reflecting on the virtual themes and debates at Molecular Med Tri-Con 2021, Head of Life Sciences Symon Cotton says that the speed of tests and vaccines coming to market is not having an adverse effect on quality. Medical developments can be safely delivered to quicker timescales...

Intravitreal Injection Syringe: It is merely a pre-filled syringe, but is it?